The present invention provides {HEAD ~ novel compounds} which bind to and are agonists, antagonists or {TAIL ~ inverse agonists} of the CB2 receptor 
are
The present invention provides { HEAD ~ novel compounds } which bind to and are agonists , antagonists or { TAIL ~ inverse agonists } of the CB2 receptor
OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH REL OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH